1. PolesD BellamyPM SpinksC et al.; on behalf ofthe Serious Hazards of Transfusion (SHOT) Steering Group:The 2018 Annual SHOT Report. Narayan S ed.2019;156–63.
2. FunkM GünayS Volz‐ZangC.HAEMOVIGILANCE REPORT OF THE PAUL‐EHRLICH‐INSTITUT 2010: Assessments of the Reports of Serious Adverse Transfusion Reactions pursuant to Section 63c AMG (Arzneimittelgesetz German Medicinal Products Act)[Internet]. Paul‐Ehrlich‐Institut (PEI Langen); 2012 [cited 2020 Mar 6]. Available from:https://www.pei.de/EN/newsroom/mandatory‐reports/haemovigilance‐reports/haemovigilance‐reports‐node.html.
3. FunkM LohmannA SprangerR et al.HAEMOVIGILANCE REPORT OF THE PAUL‐EHRLICH‐INSTITUT 2013/14: Assessments of the Reports of Serious Adverse Transfusion Reactions pursuant to Section 63i AMG (German Medicines Act)[Internet]. Paul‐Ehrlich‐Institut (PEI Langen)
4. 2016 [cited 2020 Mar 6]. Available from:https://www.pei.de/EN/newsroom/mandatory‐reports/haemovigilance‐reports/haemovigilance‐reports‐node.html.
5. FunkM HeidenM Volz‐ZangC:HAEMOVIGILANCE REPORT OF THE PAUL‐EHRLICH‐INSTITUT 2015: Assessments of the Reports of Serious Adverse Transfusion Reactions pursuant to Section 63i AMG (German Medicines Act)[Internet]. Paul‐Ehrlich‐Institut (PEI Langen); 2017 [cited 2020 Mar 6]. Available from:https://www.pei.de/EN/newsroom/mandatory‐reports/haemovigilance‐reports/haemovigilance‐reports‐node.html.